Home › Funds › Retirement Planning Co of New England, Inc. › ZVRA
Retirement Planning Co of New England, Inc. position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
Retirement Planning Co of New England, Inc. reported holding 612,329 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 2.55% of its reported portfolio and ranking #4 among its reported holdings. Retirement Planning Co of New England, Inc. has disclosed ZVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Retirement Planning Co of New England, Inc.'s ZVRA position evolved
Retirement Planning Co of New England, Inc. first disclosed a stake in ZVRA in Q3 2023 at 347,402 shares (US$1.7M). The position peaked in Q2 2026 at 634,410 shares, worth US$9.1M. Across 13 filings, Retirement Planning Co of New England, Inc. increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 612,329 shares valued at US$6.7M — a reduction of -22,081 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 347.40K | $1.67M | New |
| Q4 2023 | 387.43K | $2.54M | Add |
| Q1 2024 | 430.19K | $2.50M | Add |
| Q2 2024 | 458.30K | $2.25M | Add |
| Q3 2024 | 499.50K | $3.47M | Add |
| Q4 2024 | 514.83K | $4.29M | Add |
| Q1 2025 | 550.18K | $4.12M | Add |
| Q2 2025 | 553.30K | $4.87M | Add |
| Q3 2025 | 600.77K | $5.71M | Add |
| Q4 2025 | 662.98K | $5.94M | Add |
| Q1 2026 | 651.15K | $6.07M | Reduce |
| Q2 2026 | 634.41K | $9.10M | Reduce |
| Q3 2026 | 612.33K | $6.72M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- 683 Capital Management, LLC 855.00K sh · $12.26M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 775.00K sh · $11.11M · Q2 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Propel Bio Management, LLC 253.54K sh · $3.64M · Q2 2026
- Diametric Capital, LP 231.47K sh · $3.32M · Q2 2026
More on Retirement Planning Co of New England, Inc.
FAQ
How long has Retirement Planning Co of New England, Inc. held ZVRA?
Retirement Planning Co of New England, Inc. has disclosed ZVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Retirement Planning Co of New England, Inc.'s current position in ZVRA?
As of Q3 2026, Retirement Planning Co of New England, Inc. holds 612.33K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $6.72M, representing 2.55% of its reported portfolio and ranking #4.
Has Retirement Planning Co of New England, Inc. been buying or selling ZVRA?
In the latest 13F filing (Q3 2026), Retirement Planning Co of New England, Inc. reduced its position in ZVRA. The position peaked in Q2 2026 at 634.41K shares.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.